Beta-Blockers in Heart Failure: Pharmacy-level Intervention Comparison
2 other identifiers
interventional
220
1 country
1
Brief Summary
The overall objective of the proposed pilot study is to begin evaluation of two methods for promoting adherence to guidelines for beta-blocker therapy in heart failure. The design includes site level baseline measurement, feedback, remeasurement after six months, and randomized (by site) comparison samples. The setting is VA sites, with intervention directed at the pharmacy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable heart-failure
Started Oct 2009
Typical duration for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2009
CompletedFirst Submitted
Initial submission to the registry
October 23, 2009
CompletedFirst Posted
Study publicly available on registry
October 27, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2012
CompletedResults Posted
Study results publicly available
October 15, 2014
CompletedApril 28, 2015
September 1, 2014
1.7 years
October 23, 2009
September 26, 2014
April 6, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of Adherence to Guideline Prescription
full adherence to guideline medication and dose
6 months
Secondary Outcomes (1)
Progress Toward Adherence to Guideline Prescription
6 months
Study Arms (2)
Level 1: site-specific information
OTHERprovide site-specific information on nonadherence
Level 2: site-, patient-specific info
OTHERprovide site- and patient-specific information on nonadherence
Interventions
provide site-specific information on non-adherence to guideline
provide site-specific information on non-adherence to guideline as well as list of patients with non-adherent prescriptions
Eligibility Criteria
You may qualify if:
- VA sites
- Males and females
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Edward Hines Jr. VA Hospital, Hines, IL
Hines, Illinois, 60141-5000, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Madeline McCarren
- Organization
- Dept. of Veterans Affairs
Study Officials
- PRINCIPAL INVESTIGATOR
Madeline McCarren, PhD MPH
Edward Hines Jr. VA Hospital, Hines, IL
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2009
First Posted
October 27, 2009
Study Start
October 1, 2009
Primary Completion
June 1, 2011
Study Completion
October 1, 2012
Last Updated
April 28, 2015
Results First Posted
October 15, 2014
Record last verified: 2014-09